MDXG
Price
$7.10
Change
-$0.09 (-1.25%)
Updated
Sep 3 closing price
Capitalization
1.05B
55 days until earnings call
MGNX
Price
$1.91
Change
+$0.17 (+9.77%)
Updated
Sep 3 closing price
Capitalization
121.75M
68 days until earnings call
Interact to see
Advertisement

MDXG vs MGNX

Header iconMDXG vs MGNX Comparison
Open Charts MDXG vs MGNXBanner chart's image
MiMedx Group
Price$7.10
Change-$0.09 (-1.25%)
Volume$448.68K
Capitalization1.05B
MacroGenics
Price$1.91
Change+$0.17 (+9.77%)
Volume$1.48M
Capitalization121.75M
MDXG vs MGNX Comparison Chart in %
Loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXG vs. MGNX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXG is a Hold and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (MDXG: $7.10 vs. MGNX: $1.91)
Brand notoriety: MDXG and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXG: 57% vs. MGNX: 204%
Market capitalization -- MDXG: $1.05B vs. MGNX: $121.75M
MDXG [@Biotechnology] is valued at $1.05B. MGNX’s [@Biotechnology] market capitalization is $121.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXG’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • MDXG’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXG is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXG’s TA Score shows that 2 TA indicator(s) are bullish while MGNX’s TA Score has 3 bullish TA indicator(s).

  • MDXG’s TA Score: 2 bullish, 5 bearish.
  • MGNX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than MDXG.

Price Growth

MDXG (@Biotechnology) experienced а -0.98% price change this week, while MGNX (@Biotechnology) price change was +11.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

MDXG is expected to report earnings on Oct 29, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXG($1.05B) has a higher market cap than MGNX($122M). MDXG YTD gains are higher at: -26.195 vs. MGNX (-41.231). MDXG has higher annual earnings (EBITDA): 52.7M vs. MGNX (-26.91M). MGNX has more cash in the bank: 176M vs. MDXG (119M). MDXG has less debt than MGNX: MDXG (18.5M) vs MGNX (37.2M). MDXG has higher revenues than MGNX: MDXG (364M) vs MGNX (164M).
MDXGMGNXMDXG / MGNX
Capitalization1.05B122M861%
EBITDA52.7M-26.91M-196%
Gain YTD-26.195-41.23164%
P/E Ratio33.81N/A-
Revenue364M164M222%
Total Cash119M176M68%
Total Debt18.5M37.2M50%
FUNDAMENTALS RATINGS
MDXG vs MGNX: Fundamental Ratings
MDXG
MGNX
OUTLOOK RATING
1..100
1068
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
5198
PRICE GROWTH RATING
1..100
5661
P/E GROWTH RATING
1..100
595
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXG's Valuation (68) in the Biotechnology industry is in the same range as MGNX (79). This means that MDXG’s stock grew similarly to MGNX’s over the last 12 months.

MDXG's Profit vs Risk Rating (90) in the Biotechnology industry is in the same range as MGNX (100). This means that MDXG’s stock grew similarly to MGNX’s over the last 12 months.

MDXG's SMR Rating (51) in the Biotechnology industry is somewhat better than the same rating for MGNX (98). This means that MDXG’s stock grew somewhat faster than MGNX’s over the last 12 months.

MDXG's Price Growth Rating (56) in the Biotechnology industry is in the same range as MGNX (61). This means that MDXG’s stock grew similarly to MGNX’s over the last 12 months.

MDXG's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for MGNX (95). This means that MDXG’s stock grew significantly faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDXGMGNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WCCB40.000.25
+0.63%
West Coast Community Bancorp
RUBSF33.31N/A
N/A
RUBIS
MANZF0.29N/A
N/A
Manz Automation Ag
IDTVF31.26N/A
N/A
Industrivarden AB
HMRFF0.64-0.01
-1.16%
HOMERUN RES INC

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with INM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-1.25%
INM - MDXG
38%
Loosely correlated
-2.31%
PCVX - MDXG
36%
Loosely correlated
+1.71%
MGNX - MDXG
36%
Loosely correlated
+9.77%
CTMX - MDXG
32%
Poorly correlated
+1.92%
FULC - MDXG
32%
Poorly correlated
+1.72%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+9.77%
XNCR - MGNX
54%
Loosely correlated
-2.57%
RGNX - MGNX
53%
Loosely correlated
+8.11%
CRBU - MGNX
52%
Loosely correlated
+0.53%
BEAM - MGNX
51%
Loosely correlated
+15.02%
FATE - MGNX
50%
Loosely correlated
-2.91%
More